Shanghai ZJ Bio-Tech Co (SHSE:688317) ROCE % : 3.28% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Shanghai ZJ Bio-Tech Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Shanghai ZJ Bio-Tech Co's annualized ROCE % for the quarter that ended in Mar. 2024 was 3.28%.

Shanghai ZJ Bio-Tech Co ROCE % Historical Data

The historical data trend for Shanghai ZJ Bio-Tech Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai ZJ Bio-Tech Co ROCE % Chart

Shanghai ZJ Bio-Tech Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

11.04

110.25

34.15

22.37

-3.88

Shanghai ZJ Bio-Tech Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															0.66	3.31	0.56	-20.69	3.28

Shanghai ZJ Bio-Tech Co ROCE % Calculation

Shanghai ZJ Bio-Tech Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-156.281	/	( ( (4743.851 - 523.863)	+	(4074.191 - 236.563) )	/ 2 )
	=	-156.281	/	( (4219.988	+	3837.628)	/ 2 )
	=	-156.281	/	4028.808
	=	-3.88 %

Shanghai ZJ Bio-Tech Co's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	126.004	/	( ( (4074.191 - 236.563)	+	(4044.481 - 194.083) )	/ 2 )
	=	126.004	/	( ( 3837.628	+	3850.398 )	/ 2 )
	=	126.004	/	3844.013
	=	3.28 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Shanghai ZJ Bio-Tech Co (SHSE:688317) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Shanghai ZJ Bio-Tech Co ROCE % Related Terms

Thank you for viewing the detailed overview of Shanghai ZJ Bio-Tech Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai ZJ Bio-Tech Co (SHSE:688317) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai ZJ Bio-Tech Co Ltd (SHSE:688317) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 588 Xinjun Ring Road, Building 26, Pujiang Hi-Tech Park, Caohejing Development Zone, Shanghai, CHN

Website

https://www.liferiver.com.cn

Shanghai ZJ Bio-Tech Co Ltd is engaged in research and development, production and sales of genetic diagnostic reagents and instruments and equipment. The rapid real-time fluorescent PCR diagnostic test reagents developed by the company are mainly used in clinical medicine, public health emergencies, entry-exit inspection and quarantine, food inspection, animal husbandry, aquaculture and other fields.

Executives

Ni Wei Qin	Directors, senior managers
Shao Jun Bin	Directors, senior managers, core technical personn
Zhu Qin Wei	Core technical personnel
Lv Li Lang	senior management

Shanghai ZJ Bio-Tech Co (SHSE:688317) Headlines

No Headlines